12:00 AM
 | 
Apr 03, 2000
 |  BC Week In Review  |  Company News  |  Deals

Corixa, Wyeth Lederle deal

CRXA granted Wyeth Lederle expanded access to CRXA's monophosphoryl lipid A (MPL) adjuvant under a 1993 agreement with Ribi...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >